​

Soligenix (SNGX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SNGX Stock Rating

Soligenix stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 3 5 Strong Sell Sell Hold Buy Strong Buy

SNGX Price Target Upside V Benchmarks

TypeNameUpside
StockSoligenix-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.42$1.42$1.42
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-1---1
Mar, 26-1---1
Feb, 26-1---1
Jan, 26-1---1
Dec, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

$-80 $-64 $-48 $-32 $-16 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-67.54$-76.96$-12.66$-4.98$-2.14-
Avg Forecast$-69.60$-72.00$-13.28$-7.10$-6.75$-3.25
High Forecast$-66.18$-67.75$-12.37$-6.61$-6.29$-3.03
Low Forecast$-73.02$-76.25$-14.19$-7.59$-7.21$-3.47
Surprise %-2.96%6.89%-4.67%-29.86%-68.30%-

Revenue Forecast

$0 $170K $340K $510K $680K $850K Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$33.35K$250.00K----
Avg Forecast$666.00K$783.00K$795.00K$519.00K$800.00K$800.00K
High Forecast$691.17K$818.59K$836.84K$546.32K$842.11K$842.11K
Low Forecast$640.82K$747.41K$753.16K$491.68K$757.89K$757.89K
Surprise %-94.99%-68.07%----

Net Income Forecast

$-20M $-16M $-12M $-8M $-4M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-12.55M$-13.80M$-6.14M$-8.27M$-11.59M-
Avg Forecast$-11.46M$-13.04M$-6.14M$-3.44M$-3.27M$-1.58M
High Forecast$-9.17M$-10.44M$-4.91M$-3.21M$-3.05M$-1.47M
Low Forecast$-13.75M$-15.65M$-7.37M$-3.68M$-3.50M$-1.68M
Surprise %9.50%5.78%-140.12%254.03%-

SNGX Forecast FAQ

Is Soligenix stock a buy?

Soligenix stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Soligenix is a favorable investment for most analysts.

What is Soligenix's price target?

Soligenix's price target, set by 8 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.42.

How does Soligenix stock forecast compare to its benchmarks?

Soligenix's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Soligenix over the past three months?

  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Soligenix’s EPS forecast?

Soligenix's average annual EPS forecast for its fiscal year ending in December 2026 is $-3.25, marking a 51.87% increase from the reported $-2.14 in 2025..

What is Soligenix’s revenue forecast?

Soligenix's average annual revenue forecast for its fiscal year ending in December 2026 is $800K, reflecting a 0% decrease from the reported $0 in 2025.

What is Soligenix’s net income forecast?

Soligenix's net income forecast for the fiscal year ending in December 2026 stands at $-1.576M, representing a -86.40% decrease from the reported $-11.587M in 2025.